Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTGS2 | P35354 | 11/20 | 0.47 |
| ▸ | CYP2C9 | P11712 | 3/20 | 0.45 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.45 |
| ▸ | APP | P05067 | 1/20 | 0.45 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.45 |
| ▸ | PTGS1 | P23219 | 10/20 | 0.44 |
| ▸ | CXCR1 | P25024 | 4/20 | 0.44 |
| ▸ | CXCR2 | P25025 | 4/20 | 0.44 |
| ▸ | LMNA | P02545 | 3/20 | 0.44 |
| ▸ | SLC22A6 | Q4U2R8 | 3/20 | 0.44 |
| ▸ | MAPT | P10636 | 2/20 | 0.44 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.44 |
| ▸ | PMP22 | Q01453 | 2/20 | 0.44 |
| ▸ | CXCL8 | P10145 | 2/20 | 0.44 |
| ▸ | RECQL | P46063 | 1/20 | 0.44 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.44 |
| ▸ | HPGD | P15428 | 1/20 | 0.44 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.44 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15506106 | 1.00 | PTGS2 (0.47) | PTGS2CYP2C9CYP3A4APPCYP2C19 | |
| SCHEMBL15506197 | 1.00 | PTGS2 (0.47) | PTGS2CYP2C9CYP3A4APPCYP2C19 | |
| SCHEMBL24628718 | 0.86 | PTGS2 (0.40) | PTGS2CYP2C9CYP3A4APPCYP2C19 | |
| SCHEMBL27655291 | 0.83 | CA12 (0.43) | CYP2C9CYP3A4LMNASMN1; SMN2KDM4E | |
| SCHEMBL23198285 | 0.82 | AKR1C3 (0.54) | PTGS2CYP3A4APPCYP2C19PTGS1 | |
| SCHEMBL585616 | 0.81 | AKR1C3 (0.48) | CYP2C9CYP3A4APPCYP2C19AKR1C3 | |
| SCHEMBL490872 | 0.79 | AKR1B1 (0.47) | PTGS2CYP2C9CYP3A4APPCYP2C19 | |
| SCHEMBL490681 | 0.79 | PTGS1 (0.61) | PTGS2CYP2C9CYP3A4APPCYP2C19 | |
| SCHEMBL3858080 | 0.79 | PTGS1 (0.61) | PTGS2CYP2C9CYP3A4APPCYP2C19 | |
| SCHEMBL1741372 | 0.77 | PTGS2 (0.44) | PTGS2CYP2C9CYP3A4PTGS1CXCR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 44 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117969859-B | Metabolic biomarker for polycystic ovary syndrome and application thereof | 山东大学 | 2024-09-06 | — | — | CN | claimed |
| CN-117969859-A | Metabolic biomarker for polycystic ovary syndrome and application thereof | 山东大学 | 2024-05-03 | — | — | CN | claimed |
| CN-117969859-A | Metabolic biomarker for polycystic ovary syndrome and application thereof | 山东大学 | 2024-05-03 | — | — | CN | disclosed |
| US-11964956-B2 | Cannabinergic compounds and uses thereof | NORTHEASTERN UNIVERSITY (US) | 2024-04-23 | — | — | US | disclosed |
| CN-117843276-A | Multi-component composite steel slag grinding-aid excitant and preparation method thereof | 华新水泥股份有限公司 | 2024-04-09 | — | — | CN | disclosed |
| US-20230371552-A1 | Pet Food Compositions | HILL'S PET NUTRITION, INC. (US) | 2023-11-23 | — | — | US | disclosed |
| CN-113969251-B | Streptococcus bus and application thereof in biosynthesis of catechin derivatives | 华中农业大学 | 2023-05-02 | — | — | CN | disclosed |
| CN-113969251-A | Streptococcus basalis and application thereof in biosynthesis of catechin derivatives | 华中农业大学 | 2022-01-25 | — | — | CN | disclosed |
| US-20210101878-A1 | Cannabinergic Compounds And Uses Thereof | NORTHEASTERN UNIVERSITY | 2021-04-08 | — | — | US | disclosed |
| US-20210101878-A1 | Cannabinergic Compounds And Uses Thereof | NORTHEASTERN UNIVERSITY | 2021-04-08 | — | — | US | disclosed |
| US-10882838-B2 | Cannabinergic compounds and uses thereof | NORTHEASTERN UNIVERSITY (US) | 2021-01-05 | — | — | US | disclosed |
| US-20080152603-A1 | Antioxidants | SUSONITY Commercial GmbH (DE) | 2008-06-26 | — | — | US | disclosed |
| CN-101203278-A | Ultraviolet protection | MERCK PATENT GMBH (DE) | 2008-06-18 | — | — | CN | disclosed |
| CN-101163659-A | Antioxidants | MERCK PATENT GMBH (DE) | 2008-04-16 | — | — | CN | disclosed |
| EP-1871735-A1 | ANTIOXIDANTS | Merck Patent GmbH (DE) | 2008-01-02 | — | — | EP | disclosed |
| EP-1871339-A1 | UV PROTECTION | Merck Patent GmbH (DE) | 2008-01-02 | — | — | EP | disclosed |
| WO-2006111233-A1 | ANTIOXIDANTS | MERCK PATENT GMBH (DE) | 2006-10-26 | — | — | WO | disclosed |
| WO-2006111234-A1 | UV PROTECTION | MERCK PATENT GMBH (DE) | 2006-10-26 | — | — | WO | disclosed |
| EP-1027155-A1 | METAL COMPLEXES SUITABLE FOR ATTACHMENT TO A SUPPORT AND SUPPORTED METAL COMPLEXES | The University Court of The University of St Andrews (GB) | 2000-08-16 | — | — | EP | disclosed |
| WO-2000006298-A1 | METAL COMPLEXES SUITABLE FOR ATTACHMENT TO A SUPPORT AND SUPPORTED METAL COMPLEXES | THE UNIVERSITY COURT OF THE UNIVERSITY OF ST ANDREWS (GB) | 2000-02-10 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11964956-B2 | Cannabinergic compounds and uses thereof | CNR2, CNR1, GPR18 | PTGS2 629/4885CYP2C9 1287/4885CYP3A4 1526/4885 |
| US-20080152603-A1 | Antioxidants | GPX4, GPX1, CAT | PTGS2 320/4885CYP2C9 326/4885CYP3A4 392/4885 |
| US-10882838-B2 | Cannabinergic compounds and uses thereof | CNR2, CNR1, GPR18 | PTGS2 629/4885CYP2C9 1287/4885CYP3A4 1526/4885 |
| US-20210101878-A1 | Cannabinergic Compounds And Uses Thereof | CNR2, CNR1, GPR18 | PTGS2 629/4885CYP2C9 1287/4885CYP3A4 1526/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.